Correlation Between Dupont De and Addex Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dupont De and Addex Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dupont De and Addex Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dupont De Nemours and Addex Therapeutics, you can compare the effects of market volatilities on Dupont De and Addex Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dupont De with a short position of Addex Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dupont De and Addex Therapeutics.

Diversification Opportunities for Dupont De and Addex Therapeutics

  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Dupont and Addex is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Dupont De Nemours and Addex Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Addex Therapeutics and Dupont De is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dupont De Nemours are associated (or correlated) with Addex Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Addex Therapeutics has no effect on the direction of Dupont De i.e., Dupont De and Addex Therapeutics go up and down completely randomly.

Pair Corralation between Dupont De and Addex Therapeutics

Allowing for the 90-day total investment horizon Dupont De Nemours is expected to under-perform the Addex Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Dupont De Nemours is 2.38 times less risky than Addex Therapeutics. The stock trades about -0.08 of its potential returns per unit of risk. The Addex Therapeutics is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest  730.00  in Addex Therapeutics on November 24, 2023 and sell it today you would earn a total of  311.00  from holding Addex Therapeutics or generate 42.6% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
ValuesDaily Returns

Dupont De Nemours  vs.  Addex Therapeutics

Dupont De Nemours 

Risk-Adjusted Performance

0 of 100

Very Weak
Over the last 90 days Dupont De Nemours has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, Dupont De is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
Addex Therapeutics 

Risk-Adjusted Performance

13 of 100

Compared to the overall equity markets, risk-adjusted returns on investments in Addex Therapeutics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile basic indicators, Addex Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Dupont De and Addex Therapeutics Volatility Contrast

   Predicted Return Density   

Pair Trading with Dupont De and Addex Therapeutics

The main advantage of trading using opposite Dupont De and Addex Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dupont De position performs unexpectedly, Addex Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Addex Therapeutics will offset losses from the drop in Addex Therapeutics' long position.
The idea behind Dupont De Nemours and Addex Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Stocks Directory
Find actively traded stocks across global markets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance